HER2 is a highly relevant surface marker in certain types of breast cancer, as it promotes cell proliferation; it is overexpressed in 25-30% of breast cancers 20 and is associated with a higher risk for brain metastasis and poor prognosis. The gene discussed is ERBB2; the disease is breast carcinoma.